Key Highlights of the Report: Ø High Prevalence Rates: COPD affects approximately 10% of adults aged 40 and above in the 7MM. The aging population in these regions contributes to the increasing number of COPD cases. Ø Demographic Shift: The increasing prevalence of COPD is closely associated with aging populations, particularly in Europe and Japan. Additionally, rising...

Key Drivers Impacting Executive Summary Chronic Obstructive Pulmonary Disease (COPD) Drug Market Size and Share The global COPD drug market was valued at USD 19.8 billion in 2024 and is expected to reach USD 30.4 billion by 2032, growing at a CAGR of 4.4% during the forecast period.     Business intelligence has been employed here to create...